Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Benfield, Thomas ^a,b   Skovgaard, Marlene ^c   Schønheyder, Henrik Carl ^d   Knudsen, Jenny Dahl ^a   Bangsborg, Jette ^a   Østergaard, Christian ^a   Slotved, Hans Christian ^e   Konradsen, Helle Bossen ^e   Thomsen, Reimar Wernich ^c   Lambertsen, Lotte ^e  

^a Mental Health Center Glostrup   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ACTIVE IMMUNIZATION; ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NONBACTEREMIC PNEUMOCOCCAL PNEUMONIA; NONHUMAN; PNEUMONIA; SEROTYPE; STREPTOCOCCUS PNEUMONIA; SYMPTOM ASSESSMENT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; SEROTYPING; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE; YOUNG ADULT;

EID: 84882944993     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072743     Document Type: Article

References (30)

1. Thomsen RW, Riis A, Nørgaard M, Jacobsen J, Christensen S, et al. (2006) Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark. J Intern Med 259: 410-417. doi:10.1111/j.1365-2796.2006.01629.x. PubMed: 16594909.
2. Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, et al. (2009) New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 64: 1062-1069. doi:10.1136/thx.2008.109785. PubMed: 19454409.
3. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, et al. (2009) BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64 (Suppl 3):: iii1-ii55. doi:10.1136/thx.2009.121434. PubMed: 19783532. 64/Suppl_3/iii1. PII. doi:10.1136/thx.2009.121434.
4. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348: 1737-1746. doi:10.1056/NEJMoa022823. PubMed: 12724479.
5. Harboe ZB, Valentiner-Branth P, Benfield TL, Christensen JJ, Andersen PH, et al. (2010) Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. Vaccine 28: 2642-2647. doi:10.1016/j.vaccine.2010.01.017. PubMed: 20096392.
6. Ingels H, Rasmussen J, Andersen PH, Harboe ZB, Glismann S, et al. (2012) Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme. Vaccine 30: 3944-3950. doi:10.1016/j.vaccine.2012.03.060. PubMed: 22504662.
7. French N, Gordon SB, Mwalukomo T, White SA, Mwafulirwa G, et al. (2010) A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med 362: 812-822. doi:10.1056/NEJMoa0903029. PubMed: 20200385.
8. Mangtani P, Cutts F, Hall AJ, (2003) Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence. Lancet Infect Dis 3: 71-78. doi:10.1016/S1473-3099(03)00514-0. PubMed: 12560191.
9. Calix JJ, Porambo RJ, Brady AM, Larson TR, Yother J, et al. (2012) Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae Serotype 20 strains: discovery of a new pneumococcal serotype. J Biol Chem 287: 27885-27894. doi:10.1074/jbc.M112.380451. PubMed: 22736767.
10. Harboe ZB, Thomsen RW, Riis A, Valentiner-Branth P, Christensen JJ, et al. (2009) Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLOS Med 6: e1000081. PubMed: 19468297.
11. Weinberger DM, Harboe ZB, Sanders EA, Ndiritu M, Klugman KP, et al. (2010) Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 51: 692-699. doi:10.1086/655828. PubMed: 20715907.
12. Sjöström K, Spindler C, Ortqvist A, Kalin M, Sandgren A, et al. (2006) Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis 42: 451-459. doi:10.1086/499242. PubMed: 16421787.
13. Hausdorff WP, Feikin DR, Klugman KP, (2005) Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 5: 83-93. doi:10.1016/S1473-3099(05)70083-9. PubMed: 15680778.
14. Harboe ZB, Benfield TL, Valentiner-Branth P, Hjuler T, Lambertsen L, et al. (2010) Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis 50: 329-337. doi:10.1086/649872. PubMed: 20047478.
15. Domenech A, Ardanuy C, Calatayud L, Santos S, Tubau F, et al. (2011) Serotypes and genotypes of Streptococcus pneumoniae causing pneumonia and acute exacerbations in patients with chronic obstructive pulmonary disease. J Antimicrob Chemother 66: 487-493. doi:10.1093/jac/dkq480. PubMed: 21193476.
16. Bewick T, Sheppard C, Greenwood S, Slack M, Trotter C, et al. (2012) Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia. Thorax 67: 540-545. doi:10.1136/thoraxjnl-2011-201092. PubMed: 22374921.
17. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, et al. (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58: 377-382. doi:10.1136/thorax.58.5.377. PubMed: 12728155.
18. Rhee JY, Kwon KT, Ki HK, Shin SY, Jung DS, et al. (2009) Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock 31: 146-150. doi:10.1097/SHK.0b013e318182f98f. PubMed: 18636041.
19. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM, (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16: 128-140. doi:10.1016/0196-6553(88)90053-3. PubMed: 2841893.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR, (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383. doi:10.1016/0021-9681(87)90171-8. PubMed: 3558716.
21. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, et al. (2004) New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 57: 1288-1294. doi:10.1016/j.jclinepi.2004.03.012. PubMed: 15617955.
22. Lynge E, Sandegaard JL, Rebolj M, (2011) The Danish National Patient Register. Scand J Public Health 39: 30-33. doi:10.1177/1403494811401482. PubMed: 21775347.
23. Schønheyder HC, (1994) Clinical microbiological study of sputum and aspirates from larynx or trachea. An evaluation of exact criteria for assessment by direct microscopy]. Ugeskr Laeger 156: 5703-5707. PubMed: 7985258.
24. Kaltoft MS, Skov Sørensen UB, Slotved HC, Konradsen HB, (2008) An easy method for detection of nasopharyngeal carriage of multiple Streptococcus pneumoniae serotypes. J Microbiol Methods 75: 540-544. doi:10.1016/j.mimet.2008.08.010. PubMed: 18801391.
25. Lambertsen L, Kerrn MB, (2010) Test of a novel Streptococcus pneumoniae serotype 6C type specific polyclonal antiserum (factor antiserum 6d) and characterisation of serotype 6C isolates in Denmark. BMC Infect Dis 10: 282. doi:10.1186/1471-2334-10-282. PubMed: 20868480.
26. Chow AW, Hall CB, Klein JO, Kammer RB, Meyer RD, et al. (1992) Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infect Dis Soc America Foods Drugs Adm Clin Infect Dis 15 (Suppl 1):: S62-S88. doi:10.1093/clind/15.Supplement_1.S62.
27. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, et al. (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187: 1424-1432. doi:10.1086/374624. PubMed: 12717624.
28. Hak E, Grobbee DE, Sanders EA, Verheij TJ, Bolkenbaas M, et al. (2008) Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Neth J Med 66: 378-383. PubMed: 18990781.
29. Song JH, Dagan R, Klugman KP, Fritzell B, (2012) The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 30: 2728-2737. S0264- doi:10.1016/j.vaccine.2012.01.091. PubMed: 22330126. 410X(12)00164-8. PII. doi:10.1016/j.vaccine.2012.01.091.
30. DANMAP (2011) Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. Available: http://www.danmap.org. (Accessed July 10, 2013).